Agios Pharmaceuticals annual ebitda
2017
2018
2019
Agios Pharmaceuticals EBITDA Growth & History (AGIO)
Agios Pharmaceuticals's calculated EBITDA was −$308.2M for fiscal 2019.
View full Agios Pharmaceuticals company overviewAgios Pharmaceuticals annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2019 | 2019-12-31 | −$308.2M | $47.1M | — |
| 2018 | 2018-12-31 | −$355.3M | −$40.9M | — |
| 2017 | 2017-12-31 | −$314.4M | — | — |
Agios Pharmaceuticals quarterly ebitda
No reported data
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|
Agios Pharmaceuticals ebitda trends
Across the available reported history, Agios Pharmaceuticals's ebitda increased from −$355.3M to −$308.2M, a change of $47.1M.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Agios Pharmaceuticals filings at SEC.gov ↗